SEIDENBERG BETH C - Insider Non-Derivative Transactions at Kyverna Therapeutics, Inc. (KYTX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 18, 2025, SEIDENBERG BETH C's relationship to Kyverna Therapeutics, Inc. (KYTX) is Director, and currently has 869,317 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KYTX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

SEIDENBERG BETH C - Insider Non-Derivative Transactions of KYTX Common Stock

SEIDENBERG BETH C - Insider Non-Derivative Transactions at KYTX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 19, 2025	P -- (Common Stock)	133333	7.5	869317
May 30, 2025	Acquisition -- (Common Stock)	16634	0	16634
Feb 13, 2024	C -- (Common Stock)	735984	0	735984
Feb 13, 2024	C -- (Common Stock)	3787940	0	3787940